This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Lauridsen Group Incorporated. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Miquel Moreto Pedragosa: Innovator in Lung Health Solutions
Introduction
Miquel Moreto Pedragosa is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of lung health through his innovative research and patent.
Latest Patents
Miquel holds a patent for "Methods and compositions containing at least 30% IgG and 10% or less by weight IgA for reducing lung inflammation in an animal." This invention provides methods for reducing, attenuating, diminishing, preventing, or inhibiting pulmonary inflammation in an animal by orally administering a plasma fraction comprising at least 30% by weight IgG and 10% or less by weight IgA to said animal prior to or following exposure or challenge of the animal to an endotoxin. This patent highlights his commitment to advancing medical solutions for lung-related issues.
Career Highlights
Miquel is associated with The Lauridsen Group Incorporated, where he continues to work on innovative solutions in the health sector. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Miquel collaborates with talented professionals such as Eric Weaver and Joy M Campbell. Their combined expertise fosters a productive environment for innovation and development.
Conclusion
Miquel Moreto Pedragosa is a distinguished inventor whose work in lung health is paving the way for new therapeutic methods. His contributions are vital in the ongoing quest to improve health outcomes for individuals facing pulmonary challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile